HER2/neu and Ki-67 expression predict non-invasive recurrence following breast-conserving therapy for ductal carcinoma in situ - Concepedia

Concepedia

Publication | Open Access

HER2/neu and Ki-67 expression predict non-invasive recurrence following breast-conserving therapy for ductal carcinoma in situ

DOI Full Paper Access

128

Citations

18

References

2012

Year

Eileen Rakovitch, Sharon Nofech‐Mozes, Wedad Hanna, Steven A. Narod, Deva Thiruchelvam, Refik Saskin, Jacqueline Spayne, Colman Taylor, Lawrence Paszat

British Journal of Cancer

Abstract

Women with a HER2/neu/neu+/Ki67+ DCIS have a higher risk of developing DCIS local recurrence after breast-conserving surgery.

References

	Year	Citations

Page 1